Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA for Blood Loss in Aquablation for BPH
NCT06710327Phase 4Not yet recruiting
- Sponsor
- Kaiser Permanente
- Start
- Jan 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in benign prostatic hyperplasia (BPH), sponsored by Kaiser Permanente. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT06710327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06710327.